Mixed Response to Pfizer's Buying Wyeth

The proposed $68 billion acquisition of Wyeth by Pfizer Inc. announced yesterday was the largest the pharmaceutical industry has seen in five years, but it inspired little enthusiasm among investors, who pushed the stock prices of both companies down.

Copyright PHILY - Philly.com
Contact Us